Literature DB >> 1731777

Overexpression of amyloid precursor protein alters its normal processing and is associated with neurotoxicity.

K Fukuchi1, K Kamino, S S Deeb, A C Smith, T Dang, G M Martin.   

Abstract

The recent discovery that point mutations in the beta/A4 amyloid precursor protein may be the cause of certain forms of familial Alzheimer's disease provides strong support for the view that a thorough understanding of the metabolism of this protein may elucidate the pathogenesis of most forms of the disease and thus serve as a basis for rational prevention and therapy. Here we show that overexpression of a portion of the amyloid precursor protein molecule produces at least four distinct fragments of the COOH-terminus of amyloid precursor protein, suggesting altered proteolysis of amyloid precursor protein, and that such overexpression is associated with cytotoxicity. The degree of toxicity in the P19 cell culture model (differentiating mouse embryonal carcinoma cells) is shown to be related to the two larger novel COOH-terminal protein fragments (16 and 14 kilodalton), as well as to levels of expression of these two fragments. The toxicity is manifested in several differentiated cell lineages, including neuronal cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1731777     DOI: 10.1016/s0006-291x(05)80126-3

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

1.  High levels of circulating beta-amyloid peptide do not cause cerebral beta-amyloidosis in transgenic mice.

Authors:  K Fukuchi; L Ho; S G Younkin; D D Kunkel; C E Ogburn; R C LeBoeuf; C E Furlong; S S Deeb; D Nochlin; J Wegiel; H M Wisniewski; G M Martin
Journal:  Am J Pathol       Date:  1996-07       Impact factor: 4.307

2.  High-level expression and in vitro mutagenesis of a fibrillogenic 109-amino-acid C-terminal fragment of Alzheimer's-disease amyloid precursor protein.

Authors:  J E Gardella; G A Gorgone; L Candela; J Ghiso; E M Castaño; B Frangione; P D Gorevic
Journal:  Biochem J       Date:  1993-09-15       Impact factor: 3.857

Review 3.  The role of beta-amyloid peptide in Alzheimer's disease.

Authors:  A LeBlanc
Journal:  Metab Brain Dis       Date:  1994-03       Impact factor: 3.584

Review 4.  What can rodent models tell us about cognitive decline in Alzheimer's disease?

Authors:  Sabrina Davis; Serge Laroche
Journal:  Mol Neurobiol       Date:  2003-06       Impact factor: 5.590

5.  Age-dependent neuronal and synaptic degeneration in mice transgenic for the C terminus of the amyloid precursor protein.

Authors:  M L Oster-Granite; D L McPhie; J Greenan; R L Neve
Journal:  J Neurosci       Date:  1996-11-01       Impact factor: 6.167

6.  Association of a novel human FE65-like protein with the cytoplasmic domain of the beta-amyloid precursor protein.

Authors:  S Y Guénette; J Chen; P D Jondro; R E Tanzi
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

7.  Transgenic mice over-expressing the C-99 fragment of betaPP with an alpha-secretase site mutation develop a myopathy similar to human inclusion body myositis.

Authors:  L W Jin; M G Hearn; C E Ogburn; N Dang; D Nochlin; W C Ladiges; G M Martin
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

8.  Extracellular deposition of beta-amyloid upon p53-dependent neuronal cell death in transgenic mice.

Authors:  F M LaFerla; C K Hall; L Ngo; G Jay
Journal:  J Clin Invest       Date:  1996-10-01       Impact factor: 14.808

Review 9.  Abiotrophic gene action in Homo sapiens: potential mechanisms and significance for the pathobiology of aging.

Authors:  G M Martin
Journal:  Genetica       Date:  1993       Impact factor: 1.082

10.  Human neurons derived from a teratocarcinoma cell line express solely the 695-amino acid amyloid precursor protein and produce intracellular beta-amyloid or A4 peptides.

Authors:  A M Wertkin; R S Turner; S J Pleasure; T E Golde; S G Younkin; J Q Trojanowski; V M Lee
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.